Cargando…

Self-Assembling Nanovaccine Enhances Protective Efficacy Against CSFV in Pigs

Classical swine fever virus (CSFV) is a highly contagious pathogen, which pose continuous threat to the swine industry. Though most attenuated vaccines are effective, they fail to serologically distinguish between infected and vaccinated animals, hindering CSFV eradication. Beneficially, nanoparticl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ze-Hui, Xu, Hui-Ling, Han, Guang-Wei, Tao, Li-Na, Lu, Ying, Zheng, Su-Ya, Fang, Wei-Huan, He, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334734/ https://www.ncbi.nlm.nih.gov/pubmed/34367147 http://dx.doi.org/10.3389/fimmu.2021.689187

Ejemplares similares

Self-Assembling Nanovaccine Confers Complete Protection Against Zika Virus Without Causing Antibody-Dependent Enhancement
por: Rong, Heng, et al.
Publicado: (2022)

Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs
por: Renu, Sankar, et al.
Publicado: (2021)

HSP90AA1 interacts with CSFV NS5A protein and regulates CSFV replication via the JAK/STAT and NF-κB signaling pathway
por: Liu, Chenchen, et al.
Publicado: (2022)

Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine
por: Jin, Zhao, et al.
Publicado: (2022)

Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo
por: Lu, Ying, et al.
Publicado: (2022)

Protective RNA nanovaccines against Mycobacterium avium subspecies hominissuis
por: Touray, Bubacarr J.B., et al.
Publicado: (2023)

A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protect Pigs against a Virulent CSFV Challenge
por: Silva, Ediane, et al.
Publicado: (2023)

Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity
por: Wagner-Muñiz, Danielle A., et al.
Publicado: (2018)

Autophagy induces apoptosis and death of T lymphocytes in the spleen of pigs infected with CSFV
por: Gou, Hongchao, et al.
Publicado: (2017)

Self−Assembling Nanovaccine Fused with Flagellin Enhances Protective Effect against Foot−and−Mouth Disease Virus
por: Pei, Chenchen, et al.
Publicado: (2023)

Protein Supramolecular Structures: From Self-Assembly to Nanovaccine Design
por: Zottig, Ximena, et al.
Publicado: (2020)

Effects of Combinatorial Ubiquitinated Protein-Based Nanovaccine and STING Agonist in Mice With Drug-Resistant and Metastatic Breast Cancer
por: Huang, Fang, et al.
Publicado: (2021)

Identification of E2 with improved secretion and immunogenicity against CSFV in piglets
por: Xu, Huiling, et al.
Publicado: (2020)

Self-adjuvanting cancer nanovaccines
por: Liao, Zhiyun, et al.
Publicado: (2022)

Experimental Nanovaccine Offers Protection Against Repeat Exposures to Trypanosoma cruzi Through Activation of Polyfunctional T Cell Response
por: Chowdhury, Imran H., et al.
Publicado: (2020)

A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protects Pigs against PCV2b Challenge and Induces Serum Neutralizing Antibody Response against CSFV
por: Pavulraj, Selvaraj, et al.
Publicado: (2022)

Characterization of a Cytopathogenic Reporter CSFV
por: Reuscher, Carina Maria, et al.
Publicado: (2021)

Cholesterol Biosynthesis Modulates CSFV Replication
por: Zou, Xiaodong, et al.
Publicado: (2022)

Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses
por: Wang, Qimin, et al.
Publicado: (2020)

Immunopotentiation by Lymph-Node Targeting of a Malaria Transmission-Blocking Nanovaccine
por: Howard, Gregory P., et al.
Publicado: (2021)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

Designing self-assembled peptide nanovaccine against Streptococcus pneumoniae: An in silico strategy
por: Dorosti, Hesam, et al.
Publicado: (2019)

Lymph Node-Targeting Nanovaccine through Antigen-CpG Self-Assembly Potentiates Cytotoxic T Cell Activation
por: Xi, Xiaobo, et al.
Publicado: (2018)

Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections
por: Zacharias, Zeb R., et al.
Publicado: (2018)

Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection
por: Maina, Teresia W., et al.
Publicado: (2023)

An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer
por: Zhang, Yunting, et al.
Publicado: (2023)

Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study
por: Huang, Jian, et al.
Publicado: (2023)

Monoclonal and oligoclonal TCR AV and BV gene usage in CD4(+) T cells from pigs immunised with C-strain CSFV vaccine
por: Wang, Chunyan, et al.
Publicado: (2018)

CSFV induced mitochondrial fission and mitophagy to inhibit apoptosis
por: Gou, Hongchao, et al.
Publicado: (2017)

Dual NDP52 Function in Persistent CSFV Infection
por: Fan, Shuangqi, et al.
Publicado: (2020)

CSFV proliferation is associated with GBF1 and Rab2
por: Liang, Wulong, et al.
Publicado: (2016)

Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin
por: Peng, Bo, et al.
Publicado: (2017)

Investigation on the co-infections of Toxoplasma gondii with PRRSV, CSFV or PCV-2 in swine in part of China
por: WANG, Shuai, et al.
Publicado: (2015)

Pulmonary delivery of mucosal nanovaccines
por: Tang, Wei, et al.
Publicado: (2021)

Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells
por: Huang, Fang, et al.
Publicado: (2020)

In vitro inhibition of CSFV replication by multiple siRNA expression
por: Li, Jiangnan, et al.
Publicado: (2011)

Corrigendum: Dual NDP52 Function in Persistent CSFV Infection
por: Fan, Shuangqi, et al.
Publicado: (2021)

Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
por: Fang, Xingliang, et al.
Publicado: (2022)

Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report
por: Shao, Jie, et al.
Publicado: (2022)

Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice
por: Martínez-Pérez, Amparo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6t90ufrr4u1ko4ui01023riun6